Sorry, no posts matched your criteria.
Comments
No Responses to “”Trackbacks
Check out what others are saying about this post...-
[...] The effort to renew Third Frontier began late last year when two legislators proposed issuing $1 billion in bonds to fund an additional five years’ of grants from the program. Two weeks ago, the Ohio House trimmed that to a $950 million bond issue. Last week, the Ohio Senate halved the original bond issue to $500 million. [...]
-
[...] Ohio, the biggest deals were: Akebia Therapeutics, the Cincinnati developer of small-molecule drugs for anemia and vascular disorders, which raised [...]
-
[...] people who sit on the Third Frontier’s commission and advisory board concluded the project likely would pay back taxpayers by 2014 — with just sales and payroll taxes generated by businesses and industries it [...]
-
[...] additional five years’ of grants from the program. Two weeks ago, the Ohio House trimmed that to a $950 million bond issue. Last week, the Ohio Senate halved the original bond issue to $500 [...]
-
[...] Visit link: Ohio Third Frontier stakeholders hope for nearly full funding for 5-year extension (MedCity News) [...]
-
[...] plans, according to Bucks Consulting. After the growth in total U.S. health spending slowed significantly last year due to the recession, these numbers suggest a return to the bad old days of [...]
-
[...] At this link you can see the FDA’s/CDRH complete FY10 planning document. There is a lot of information in the document as well about the planned overhaul of the 510(k) and pre-market approval processes. For a quick summary of the overall implications, you can read a good news overview courtesy of this MedCity News posting. [...]
-
[...] Brandon Glenn at Medcity does a great job summarizing the Ipad’s limitations [...]
-
[...] hit a major milestone in December, when it signed a licensing deal with pharmaceuticals giant GlaxoSmithKline for its cold sore drug. The licensing agreement, the company’s first, could be worth more [...]
-
[...] J. Drachman, president and chief executive, said in November that fighting the lawsuit would have distracted the managers of his emerging, growth-oriented company, and probably would have cost too much, even if the [...]
-
[...] biggest economic development project beyond its fiscal 2012 term is a compromise between the $950 million adopted by the House and $500 million plus $100 million in Public Works money adopted by the [...]
-
[...] is great politics. The state amendments are tasty red meat for conservative voters who oppose–or don’t understand–the federal health overhaul. If these empty gestures get more Republican voters to the polls [...]
-
[...] of the company’s efforts to get every dollar’s worth of value from its services after spinning off its medical technology business CareFusion. In recent months Cardinal also created a new service to [...]
-
[...] week Cardinal announced better than expected quarterly earnings. Chief Executive George Barrett said then the post-CareFusion transition was a “marathon, not [...]
-
[...] medical technology business CareFusion. In recent months, Cardinal also created a new service to target mail-order pharmacies as well as supply chain management [...]
-
[...] Jude reported last week that fourth-quarter sales in its cardiac rhythm management division fell one percent. The division’s annual sales grew three percent, most if it from [...]
-
[...] But the television network is indicative of the company’s efforts to get every dollar’s worth of value from its services since spinning off its medical technology business CareFusion. In recent months, Cardinal also created a new service to target mail-order pharmacies as well as supply chain management software. [...]
-
[...] beyond its fiscal 2012 term is a compromise between the $950 million adopted by the House and $500 million plus $100 million in public works money adopted by the [...]
-
[...] year ago, STERIS asked the FDA to approve a kind of System 1.5. “While we are focused to assist customers as they look to transition from System 1, we [...]
-
[...] to renew the state’s most ambitious economic development project began late last year when two legislators proposed issuing $1 billion in bonds to fund an additional five years. Third Frontier invests in technology research, development, [...]
-
[...] 2003. Supporters have been quietly raising money, forming a committee and planning a strategy for a voter campaign on the ballot initiative, said Dorothy Baunach, special adviser on the Third Frontier to the Ohio Business [...]
-
[...] publicly disclosed, according to the Wall Street Journal. Medtronic, based in Fridley, pulled the Sprint Fidelis defibrillator wires off the market in 2007 and substituted another type of wire with a lower failure rate. But an [...]
-
[...] And one Invacare specter appears to have been vanquished — a tax on medical device sales proposed under health care reform that would have cost Invacare between $12 million and $14 million a year. [...]
-
[...] St. Jude said it had received FDA approval to begin enrolling patients in a clinical trial of a catheter system that uses radio frequency energy to destroy abnormal heart [...]
-
[...] sale of Youngstown’s Forum Health, which is reorganizing under Chapter 11 bankruptcy protection, to Nashville, Tenn., hospital system Ardent Health Services hinges on successful negotiations [...]
-
[...] I’m not sure what caused Lenczewski’s change of heart or the fate of her grants bill. Next Tuesday, a joint hearing of the House Tax and Bioscience and Workplace Development committees will examine Lenczewski’s proposals and another angel bill carefully crafted by the Pawlenty Administration, Democratic lawmakers, and bus… [...]
-
[...] Thomas Lee, Med City News “ST. PAUL, Minnesota– I’ll say this about Rep. Ann Lenczewski: she certainly makes [...]
-
[...] Lenczewski did not immediately respond to a phone call and e-mail. But she did send yours truly a blistering reply to a column I recently wrote that slammed her grants proposal. [...]
-
[...] a regulatory document last week with the Securities and Exchange Commission stating it had raised $31 million, the Wisconsin company amended that filing with another one. The company now says it has raised [...]
-
[...] early December, UH streamlined its clinical and non-clinical operations and brought in some new faces to lead continued growth during a period that Chief Operating Officer [...]
-
[...] the Minnesota High Tech Association support a bill authored by Sen. Kathy Saltzman that calls for a four year, $40 million tax credits for people and funds that invest in start-up companies like medical devices, pharmaceuticals, and [...]
-
[...] ♦ A $700 million renewal of Ohio Third Frontier — the 10-year, $1.6 billion project to re-energize Ohio’s economy by investing in emerging [...]
-
[...] The week in deals: Cellular Dynamics International Inc. in Madison, Wis., raised an additional $31 million… Cleveland, Ohio’s, CardioInsight Technologies closed its second funding round, [...]
-
[...] funding… Health care laundry company Superior Health Linens LLC in Cudahy, Wis., has raised $1.5 million in equity… Cincinnati, Ohio, nonprofit health information exchange HealthBridge has received [...]
-
[...] the university biomedical researchers into viable start-ups. A key component to the center is a $20 million private venture capital fund that will support the [...]
-
[...] heart-mapping technology… Pittsburgh, Pa.’s, Foundation Radiology Group has raised a $4 million Series B round of funding… Health care laundry company Superior Health Linens LLC in Cudahy, [...]
-
[...] Cleveland, Ohio’s, CardioInsight Technologies closed its second funding round, raising $6 million from new and existing investors to speed and expand testing and commercialization of its [...]
-
[...] was chief executive of CoreValve, an Irvine, Calif., cardiovascular device firm that was acquired for $700 million by Medtronic last year. Prior to that, Lemaitre was a senior [...]
-
[...] came here because the basic science is really outstanding,” Rixe said in a January interview. “This is an opportunity to develop new strategies with new targeted agents, with [...]
A Next Generation News Service
MedCity News covers the business of health care
and delivers news on your terms. Read our
coverage at MedCityNews.com or through our
syndication partners.
Daily updates from MedCity News.
Subscribe to the MedCity News' e-newsletter
by entering your e-mail below.
BusinessWire Feed
- Skilled Healthcare Group Reports Full Year 2009 Results
- AGA Medical to Host Earnings Conference Call on Tuesday, February 16, 2010
- Forward Reports Fiscal 2010 First Quarter Results
- PPD Reports Fourth Quarter and Full Year 2009 Financial Results
- Owens & Minor Reports Strong 2009 Financial Results
- Charles River Announces Fourth-Quarter and Full-Year 2009 Results and Provides 2010 Guidance
- Teleflex Announces Conference Call Information for Fourth Quarter and Year-End 2009 Earnings
- Lannett Reports Fiscal 2010 Second-Quarter Financial Results
- National Mentor Holdings, Inc. To Hold First Quarter FY10 Conference Call
- CardioNet, Inc. to Release Fourth Quarter and Full Year 2009 Earnings Results on February 17, 2010
Is this the same process that Neuralstem is doing with Emory that involves a laminectomized patient in order to deliver the injections into the spinal cord? Why is U. of Michigan doing the same thing that Emory/Neuralstem are? Is this using “neural stemcells” ( mesenchymal?) from the eight week old fetus as written up recently?